Title : A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet.

Pub. Date : 2016 Apr 14

PMID : 27075683






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Therefore, we investigated whether oral administration of sulforaphane (SFN) prevented high-fat diet-induced NAFLD in mice by regulation of the NLRP3 inflammasome in the liver. sulforaphane NLR family, pyrin domain containing 3 Mus musculus
2 Therefore, we investigated whether oral administration of sulforaphane (SFN) prevented high-fat diet-induced NAFLD in mice by regulation of the NLRP3 inflammasome in the liver. sulforaphane NLR family, pyrin domain containing 3 Mus musculus
3 These were correlated with the suppression of NLRP3 inflammasome activation in the liver by SFN as evidenced by decrease in mRNA levels of ASC and caspase-1, caspase-1 enzyme activity, and IL-1beta levels. sulforaphane NLR family, pyrin domain containing 3 Mus musculus
4 SFN inhibited saturated fatty acid-induced activation of the NLRP3 inflammasome in primary mouse hepatocytes, accompanied by the restoration of mitochondrial dysfunction. sulforaphane NLR family, pyrin domain containing 3 Mus musculus
5 The suppression of NLRP3 inflammasome by SFN was mediated by the regulation of AMP-activated protein kinase-autophagy axis. sulforaphane NLR family, pyrin domain containing 3 Mus musculus